NEONATAL THROMBOCYTOPENIA AND CONGENITAL MALFORMATIONS ASSOCIATED WITH ADMINISTRATION OF TOLBUTAMIDE TO MOTHER

被引：36

作者：

SCHIFF, D

ARANDA, JV

STERN, L

机构：

来源：

关键词：

D O I：

10.1016/S0022-3476(70)80015-4

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页码：457 / +

共 10 条

[1]

CAMPBELL GD, 1961, LANCET, V1, P891

[2]

CHULSKI T, 1959, J LAB CLIN MED, V53, P490

[3]

DOLGER H, 1969, J MT SINAI HOSP, V36, P471

[4] BLOOD DYSCRASIAS ASSOCIATED WITH TOLBUTAMIDE THERAPY [J].

JOST, F .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1959, 169 (13) :1468-1469

[5]

LARSSON Y, 1960, LANCET, V2, P1424

[6]

MILLER DI, 1962, DIABETES S11, P93

[7] STUDIES ON OXIDATIVE DRUG METABOLISM IN FULL-TERM NEWBORN INFANT [J].

NITOWSKY, HM ;

MATZ, L ;

BERZOFSK.JA .

[8]

PEDERSEN LM, 1964, LANCET, V1, P1124

[9] THE PHARMACOLOGY OF CHLORPROPAMIDE [J].

SCHNEIDER, JA ;

SALGADO, ED ;

JAEGER, D ;

DELAHUNT, C .

[10]

STERN L, 1965, LANCET, V1, P1393